FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials

from Referral

The following topics will be discussed to provide the foundation and basis for advancing drugs into clinical development from research and providing required information to the FDA regarding these products. (from )

Something wrong? Flag this event